CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment

Cryoablation demonstrated feasibility in progressive DT pts. The study met is primary end-point with 86% of non-progressive disease at +12  months, with reduced pain, better functional status, and encouraging long-term disease control.

Source: European Journal of Cancer - December 5, 2020 Category: Cancer & Oncology Authors: Jean-Emmanuel Kurtz, Xavier Buy, Fr édéric Deschamps, Erik Sauleau, Amine Bouhamama, Maud Toulmonde, Charles Honoré, François Bertucci, Mehdi Brahmi, Christine Chevreau, Florence Duffaud, Justine Gantzer, Julien Garnon, Jean-Yves Blay, Afshin Gangi Tags: Original Research Source Type: research